These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30349265)

  • 21. Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex.
    Mir-Moghtadaei A; Caballero R; Fried P; Fox MD; Lee K; Giacobbe P; Daskalakis ZJ; Blumberger DM; Downar J
    Brain Stimul; 2015; 8(5):965-73. PubMed ID: 26115776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Task-related functional magnetic resonance imaging-based neuronavigation for the treatment of depression by individualized repetitive transcranial magnetic stimulation of the visual cortex.
    Zhang Z; Zhang H; Xie CM; Zhang M; Shi Y; Song R; Lu X; Zhang H; Li K; Wang B; Yang Y; Li X; Zhu J; Zhao Y; Yuan TF; Northoff G
    Sci China Life Sci; 2021 Jan; 64(1):96-106. PubMed ID: 32542515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of quantitative electroencephalograms following prefrontal repetitive transcranial magnetic stimulation in patients with major depression.
    Noda Y; Nakamura M; Saeki T; Inoue M; Iwanari H; Kasai K
    Neurosci Res; 2013; 77(1-2):70-7. PubMed ID: 23827366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of response to repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder.
    Beuzon G; Timour Q; Saoud M
    Encephale; 2017 Feb; 43(1):3-9. PubMed ID: 28034451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranetwork and Internetwork Effects of Navigated Transcranial Magnetic Stimulation Using Low- and High-Frequency Pulse Application to the Dorsolateral Prefrontal Cortex: A Combined rTMS-fMRI Approach.
    Zhang H; Sollmann N; Castrillón G; Kurcyus K; Meyer B; Zimmer C; Krieg SM
    J Clin Neurophysiol; 2020 Mar; 37(2):131-139. PubMed ID: 30335664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of repetitive transcranial magnetic stimulation for alleviating clinical symptoms and suicidal ideation in elderly depressive patients: a randomized controlled trial].
    Qin BY; Dai LL; Zheng Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):97-101. PubMed ID: 28109107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentative repetitive Transcranial Magnetic Stimulation (rTMS) in the acute treatment of poor responder depressed patients: a comparison study between high and low frequency stimulation.
    Dell'Osso B; Oldani L; Camuri G; Dobrea C; Cremaschi L; Benatti B; Arici C; Grancini B; Altamura AC
    Eur Psychiatry; 2015 Feb; 30(2):271-6. PubMed ID: 25572482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder.
    Hunter AM; Minzenberg MJ; Cook IA; Krantz DE; Levitt JG; Rotstein NM; Chawla SA; Leuchter AF
    Brain Behav; 2019 May; 9(5):e01275. PubMed ID: 30941915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder.
    Wang YM; Li N; Yang LL; Song M; Shi L; Chen WH; Li SX; Wang XY; Lu L
    Psychiatry Res; 2017 Aug; 254():18-23. PubMed ID: 28441583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity.
    Padberg F; Zwanzger P; Keck ME; Kathmann N; Mikhaiel P; Ella R; Rupprecht P; Thoma H; Hampel H; Toschi N; Möller HJ
    Neuropsychopharmacology; 2002 Oct; 27(4):638-45. PubMed ID: 12377400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Affective disorders and repetitive transcranial magnetic stimulation: Therapeutic innovations].
    Richieri R; Adida M; Dumas R; Fakra E; Azorin JM; Pringuey D; Lancon C
    Encephale; 2010 Dec; 36 Suppl 6():S197-201. PubMed ID: 21237356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontostriatal Connectivity Changes in Major Depressive Disorder After Repetitive Transcranial Magnetic Stimulation: A Randomized Sham-Controlled Study.
    Kang JI; Lee H; Jhung K; Kim KR; An SK; Yoon KJ; Kim SI; Namkoong K; Lee E
    J Clin Psychiatry; 2016 Sep; 77(9):e1137-e1143. PubMed ID: 27379563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamate alterations associated with transcranial magnetic stimulation in youth depression: a case series.
    Yang XR; Kirton A; Wilkes TC; Pradhan S; Liu I; Jaworska N; Damji O; Keess J; Langevin LM; Rajapakse T; Lebel RM; Sembo M; Fife M; MacMaster FP
    J ECT; 2014 Sep; 30(3):242-7. PubMed ID: 24820947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.
    Hunter AM; Nghiem TX; Cook IA; Krantz DE; Minzenberg MJ; Leuchter AF
    Clin EEG Neurosci; 2018 Sep; 49(5):306-315. PubMed ID: 29224411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.